CAI
Caris Life Sciences, Inc. Common Stock
NASDAQ: CAI · HEALTHCARE · BIOTECHNOLOGY
$17.77
-3.63% today
Updated 2026-04-29
Market cap
$5.02B
P/E ratio
—
P/S ratio
6.19x
EPS (TTM)
$-3.22
Dividend yield
—
52W range
$16 – $43
Volume
2.3M
Caris Life Sciences, Inc. Common Stock (CAI) Financial statements
SEC filings — annual and quarterly data.
Balance sheet — annual
| Item | 2004 | 2005 | 2006 | 2007 | 2008 | 2009 | 2010 | 2011 | 2012 | 2013 | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Total assets | $181.96M | $180.66M | $283.00M | $359.10M | $412.63M | $374.08M | $613.45M | $953.37M | $1.39B | $1.68B | $1.80B | $1.99B | $2.06B | $2.43B | $3.01B | $2.90B | $2.61B | $717.42M | $412.90M | $343.73M |
| Cash & equivalents | $5.53M | $7.57M | $20.36M | $8.43M | $28.54M | $14.49M | $14.39M | $14.08M | $17.67M | $45.74M | $53.82M | $52.55M | $46.13M | $35.42M | $45.31M | $46.46M | $53.55M | $107.19M | $56.40M | $63.95M |
| Current assets | $5.53M | $41.40M | $59.52M | $53.43M | $80.99M | $63.38M | $68.65M | $74.90M | $95.11M | $130.97M | $144.80M | $144.11M | $135.15M | $140.34M | $220.02M | $499.13M | $214.66M | $516.04M | $242.61M | $215.73M |
| Total liabilities | $158.14M | $147.67M | $255.25M | $227.95M | $298.84M | $244.99M | $415.78M | $704.63M | $1.04B | $1.26B | $1.35B | $1.53B | $1.60B | $1.87B | $2.31B | $2.21B | $1.91B | $2.42B | $2.56B | $2.84B |
| Current liabilities | — | $44.97M | $77.56M | $56.63M | $45.24M | $38.45M | $154.16M | $79.05M | $106.78M | $156.94M | $249.19M | $217.88M | $164.01M | $259.93M | $425.53M | $287.41M | $320.25M | $136.91M | $95.14M | $165.42M |
| Long-term debt | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | $169.57M | $166.11M | $319.19M |
| Shareholder equity | $23.82M | $32.99M | $27.75M | $131.15M | $113.79M | $129.10M | $179.60M | $230.04M | $346.85M | $414.53M | $442.12M | $460.34M | $457.50M | $563.85M | $701.13M | $693.24M | $702.24M | $-1.70B | $-2.14B | $-2.50B |
| Retained earnings | — | $30.52M | $26.40M | $40.06M | $13.10M | $26.66M | $55.04M | $105.23M | $168.70M | $232.62M | $292.90M | $319.74M | $324.58M | $397.64M | $471.11M | $493.29M | $503.32M | $-1.68B | $-2.12B | $-2.47B |
| Accounts receivable | — | $27.46M | $31.92M | $35.23M | $40.91M | $33.37M | $40.37M | $45.44M | $62.38M | $64.87M | $76.17M | $76.44M | $83.70M | $100.66M | $171.92M | $159.68M | $144.30M | $40.23M | $55.30M | $88.24M |
| Inventory | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | $46.96M | $49.00M | $39.57M |
| Goodwill | — | — | $50.25M | $50.25M | — | — | — | — | — | — | — | $2.90M | $15.79M | $15.79M | $15.79M | $15.79M | — | $19.34M | $19.34M | $19.34M |